Healthpeak Properties FY 2025 earnings snapshot

Healthpeak Properties (DOC) has reported new figures for FY 2025, with Q4 total revenue of US$719.4 million, basic EPS of US$0.16 and net income of US$113.8 million. These results contributed to a full year in which trailing twelve month revenue was about US$2.8 billion and EPS was US$0.10. Over recent quarters, the company’s revenue moved from US$697.9 million in Q4 FY 2024 to US$719.4 million in Q4 FY 2025, while quarterly EPS ranged from a loss of US$0.17 to a profit of US$0.16. This highlights the importance of margins for investors assessing these results.

See our full analysis for Healthpeak Properties.

With the latest figures available, the next step is to see how these margins and earnings trends align with the widely followed growth and risk narratives around Healthpeak Properties.

FFO holds steady around US$320 million

• Funds From Operations, a key cash flow measure for REITs, stayed in a tight band between US$303.6 million and US$328.6 million across the last four quarters, with Q4 at US$328.6 million and trailing 12 month FFO at about US$1.27b.
• What analysts with a bullish view are watching is how this relatively steady FFO base might interact with forecasts that earnings grow about 21.6% per year, even though revenue is only expected to grow around 3.5% per year. This assumes margin improvement on top of these cash flow levels.
  • That higher earnings growth expectation sits against a trailing net margin of 2.5%, which is lower than the 9% margin a year earlier.
  • The trailing period also includes a US$54.5 million one off gain in earnings, so bulls need to separate repeatable cash flow from items that do not recur.

Over the past year, steady FFO and modest top line growth are exactly the kind of building blocks bullish investors point to when they argue the story is more about improving margins and asset efficiency than headline revenue alone. 🐂 Healthpeak Properties Bull Case

Margins soften to 2.5% net income

• On a trailing 12 month basis, net income sits at US$70.5 million on about US$2.82b of revenue, which works out to a 2.5% net margin compared with 9% a year earlier, and includes a US$54.5 million one off gain that affects how clean that profit figure looks.
• Skeptics focus on this margin compression and weak interest coverage, arguing that even if earnings are forecast to grow, the combination of lower profitability and interest payments that are not well covered by earnings could limit how comfortably the REIT can fund growth or support an unstable dividend record.
  • The risk summary flags that earnings currently do not cover interest expense well, which ties directly into concerns about leverage and refinancing.
  • Dividend history is also described as unstable, which matters for a REIT where many investors pay close attention to income reliability.

Bears point to the drop in trailing margin and the pressure from interest coverage to argue that headline earnings forecasts may not fully reflect balance sheet and income statement pressures. 🐻 Healthpeak Properties Bear Case

DCF fair value and price target vs US$16.51 share price

• At a current share price of US$16.51, the stock screens below both an analyst DCF fair value of about US$31.33 and an analyst price target of US$19.47, while also trading on lower P/S multiples than peers, according to the valuation summary.
• The prevailing market narrative balances this apparent discount with the financial risks. While a lower price relative to DCF fair value and the analyst target looks appealing, investors still need to weigh that against the 2.5% trailing margin, the role of the US$54.5 million one off gain, and interest coverage that is described as weak.
  • Forecast earnings growth of roughly 21.6% per year is one part of the argument that the current price may not fully reflect future profit potential.
  • At the same time, modest forecast revenue growth of about 3.5% per year and the recent margin profile mean expectations for that profit growth rely heavily on better efficiency rather than a big acceleration in sales.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Healthpeak Properties on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With both risks and rewards in play, the story around Healthpeak Properties is far from one sided. Check the underlying data, weigh the trade offs, and review the 3 key rewards and 4 important warning signs.

See What Else Is Out There

Healthpeak Properties combines a 2.5% trailing net margin, weak interest coverage, and an unstable dividend record, which raises questions about earnings quality and income reliability.

If those pressure points concern you, compare this situation with companies screened for stronger income support and more reliable cash returns through the 12 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.